Computerized tests for evaluation of sedative drugs on attention and mental function of study participants
- Registration Number
- CTRI/2014/10/005102
- Lead Sponsor
- izams Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 15
1. Participants of either gender between 18-45 years of age and BMI of 18.5 to < 25 kg/m2.
2. Participants willing to sign informed consent.
3. Participants with normal physical, clinical examination and lab investigations.
4. Able to perform the test procedures, as per the protocol.
5. Participants with normal to corrected vision.
6. Able to read English words
1. H/o of psychiatric illiness, insomnia, use of any psychiatric medication.
2. H/o of drug dependence or any severe co-morbid medical conditions.
3. H/o of serious adverse reactions or hypersensitivity to any drug.
4. Abnormality in lab investigations like complete blood picture, complete urine examination, liver function tests or renal function tests.
5. Participating in any drug trials/ research projects over the past 3 months.
6. Alcohol consumption 24 hrs before study day.
7. Tea / Coffee consumption or smoking 12 hrs before the study day.
8. Pregnant/breast feeding/ child bearing potential participants
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference in attention and cognitive function as assessed by Simple reaction time, cued reaction time and Inhibitory control using Computerized stroop color word test part 1, 2 and 3 respectively.Timepoint: Three time points <br/ ><br>1. Baseline <br/ ><br>2. One hour post administration of study drug <br/ ><br>3. Two hour post administration of study drug
- Secondary Outcome Measures
Name Time Method Stroop Mean color word Inference scoreTimepoint: Three time points <br/ ><br>1. Baseline <br/ ><br>2. One hour post administration of study drug <br/ ><br>3. Two hour post administration of study drug